Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance. (Q52588299)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

title

Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Daniel W Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

E David Crawford

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

Thomas Keane

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

Brent Evans

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

Julia Reid

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

Saradha Rajamani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

Krystal Brown

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

Alexander Gutin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

Peter Scardino

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

Michael Brawer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

Steven Stone

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

publication date

11 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

310.e7-310.e13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

23 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

20-year outcomes following conservative management of clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

Mortality results from a randomized prostate-cancer screening trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

Radical prostatectomy versus observation for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

Guideline for the management of clinically localized prostate cancer: 2007 update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

Current status of active surveillance in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

Active surveillance for prostate cancer: a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2018.03.011

10.1016/J.UROLONC.2018.03.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29655620 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference